A literature-based network analysis by Tseng et al. suggested that STAT3 signaling is a key factor in regulating cancer-related biomolecular signatures and pathways in ATC-CD133+ cells that are strongly associated with dedifferentiation and thyroid tumorigenesis [116]. This evidence concerns the gene STAT3 and cancer.